1. Baseline characteristics for CLARITY AD: A phase 3 placebo‐controlled, double‐blind, parallel‐group, 18‐month study evaluating lecanemab (ban2401) in early Alzheimer's disease. (31st December 2021) Authors: Lynch, Shau Yu; Irizarry, Michael C; Dhadda, Shobha; Li, David JianJun; Kanekiyo, Michio; Bogoslovsky, Tanya; Gee, Michelle; Reyderman, Larisa; Kaplow, June; Rabe, Martin; Hodgkinson, Mark; Kramer, Lynn D; Hampel, Harald; Swanson, Chad J Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bioengineered 3D Tissue Model of Intestine Epithelium with Oxygen Gradients to Sustain Human Gut Microbiome. Issue 16 (19th June 2022) Authors: Chen, Ying; Rudolph, Sara E.; Longo, Brooke N.; Pace, Fernanda; Roh, Terrence T.; Condruti, Rebecca; Gee, Michelle; Watnick, Paula I.; Kaplan, David L. Journal: Advanced healthcare materials Issue: Volume 11:Issue 16(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Diversity in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Lecanemab and Elenbecestat Early Alzheimer's Disease Studies. (20th December 2022) Authors: Grill, Joshua; Molina‐Henry, Doris P.; Sperling, Reisa A.; Dhadda, Shobha; Tranotti, Kate; Harris, Russell; Devins, Theresa; Swanson, Chad J; Kanekiyo, Michio; Gee, Michelle; Irizarry, Michael C; Kramer, Lynn D; Aisen, Paul; Raman, Rema Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 10 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach. (June 2014) Authors: Inamdar, Amir; Merlo-Pich, Emilio; Gee, Michelle; Makumi, Clare; Mistry, Prafull; Robertson, Jon; Steinberg, Erik; Zamuner, Stefano; Learned, Susan; Alexander, Robert; Ratti, Emiliangelo Journal: Journal of psychopharmacology Issue: Volume 28:Number 6(2014:Jun.) Page Start: 570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Initial exploration of a brain age score based on validated computerized cognitive assessments in Japanese individuals: Neuropsychology/Multicultural issues in assessment of dementia. (7th December 2020) Authors: Edgar, Chris J.; Schembri, Adrian; Maruff, Paul T.; Gee, Michelle; Iwatsubo, Takeshi; Aisen, Paul S.; Sperling, Reisa A.; Irizarry, Michael C. Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 6 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. InVitro Models of Intestine Innate Immunity. Issue 3 (March 2021) Authors: Roh, Terrence T.; Chen, Ying; Rudolph, Sara; Gee, Michelle; Kaplan, David L. Journal: Trends in biotechnology Issue: Volume 39:Issue 3(2021) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lead Discovery for Human Kynurenine 3-Monooxygenase by High-Throughput RapidFire Mass Spectrometry. (April 2014) Authors: Lowe, Denise M.; Gee, Michelle; Haslam, Carl; Leavens, Bill; Christodoulou, Erica; Hissey, Paul; Hardwicke, Philip; Argyrou, Argyrides; Webster, Scott P.; Mole, Damian J.; Wilson, Kris; Binnie, Margaret; Yard, Beverley A.; Dean, Tony; Liddle, John; Uings, Iain; Hutchinson, Jonathan P. Journal: Journal of biomolecular screening Issue: Volume 19:Number 4(2014) Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. LONG-TERM SAFETY OF PERAMPANEL: ADDITIONAL 10 MONTHS OF DATA FROM EXTENSION STUDY 307 IN PATIENTS WITH PARTIAL-ONSET SEIZURES AGED 12 AND ABOVE. Issue 10 (9th September 2014) Authors: Clément, Jean-François; Krauss, Gregory; Pillay, Neelan; McLachlan, Richard; Hwang, Paul; Bagul, Makarand; Zhu, Jin; Gee, Michelle Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 85:Issue 10(2014) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LONG-TERM SEIZURE OUTCOMES WITH PERAMPANEL IN REFRACTORY PARTIAL-ONSET SEIZURES AND SECONDARILY GENERALISED PARTIAL SEIZURES: 10 MONTHS ADDITIONAL DATA FROM EXTENSION STUDY 307 FOLLOWING THREE PHASE III CLINICAL TRIALS. Issue 10 (9th September 2014) Authors: Ben-Menachem, Elinor; Krauss, Gregory; Bagul, Makarand; Zhu, Jin; Gee, Michelle Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 85:Issue 10(2014) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long‐term safety of perampanel and seizure outcomes in refractory partial‐onset seizures and secondarily generalized seizures: Results from phase III extension study 307. Issue 7 (27th May 2014) Authors: Krauss, Gregory L.; Perucca, Emilio; Ben‐Menachem, Elinor; Kwan, Patrick; Shih, Jerry J.; Clément, Jean‐François; Wang, Xuefeng; Bagul, Makarand; Gee, Michelle; Zhu, Jin; Squillacote, David Journal: Epilepsia Issue: Volume 55:Issue 7(2014:Jul.) Page Start: 1058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗